Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Will Big Pharma Acquire Novavax?

TheMotleyFool

0 0

Will Big Pharma Acquire Novavax?Photo, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Novavax (NASDAQ: NVAX) has had a phenomenal year in 2020. The mid-cap opened in January as a micro-cap, starting off the year at $4 a share. Nine months later, its shares are trading hands for $113. That's a remarkable upgrade in valuation.

Novavax is a vaccine specialist, and the demand for vaccines has increased dramatically because of COVID-19. This virus has done trillions of dollars' worth of economic damage and has killed at least a million people worldwide. Most of humanity is going to need to be vaccinated, and governments are already paying billions to make that happen.

Let's look at why a major pharmaceutical company might want to acquire Novavax.

Source Fool.com

Like: 0

NVAX

Share